Roivant reports Q1 2026 financial results
Roivant reported Q1 2026 results, highlighting a $3.9B cash balance and a settlement with Moderna.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day